Monday, September 16, 2013 12:15:36 PM
Personal Alert
Personal Alert
Livefyre
Post comment as...
Commenting is limited to medical professionals. To comment please Log-in.
Commenting is moderated. See our Terms of Use.
16 comments
Newest | Oldest
Dr. christopher ogiehor
Dr. christopher ogiehor
11 hours ago
thanks for this information but how does the increase in blood flow causing enlargement solve the urinary symptoms-e.g. reduced flow ,frequency, urgency incontinence etc?
Dr. tony Awukam
Dr. tony Awukam
Aug 28, 2013
Fantastic!. Conquering ED without the systemic effects of PDE-5 inhibitors.
Nan Sachsel
Nan Sachsel
Aug 20, 2013
What side effects are there, if any, in the partners of men using this topical ? I presume a fair portion of the medication remains on the skin and would be transferred and absorbed during intercourse.
Dr. charles metzger
Dr. charles metzger
Jul 30, 2013
I think it is mostly the technique of application that determines its efficacy
Dr. ELIAKIM MANDA
Dr. ELIAKIM MANDA
Jul 30, 2013
The news about Vitaros is very exciting to the Urology field.
Dr. asad hillis
Dr. asad hillis
Jul 19, 2013
thank you for this information and hop to find this cream in our contry
Dr. arunava choudhury
Dr. arunava choudhury
Jul 10, 2013
What an ideà.we thought that all local appln were hocus pocus.now we have awonder lotion?
Dr. Graham Rix
Dr. Graham Rix
Jul 7, 2013
Dr Mulhall's poster presentation claims an improvement of between 1.6 and 2.5 points (IIEF-EF) in the treated patients. This is less than most ED-treatment trials achieve in the placebo group.
The only previous double-blind trial failed to complete when more than 50% of patients left before the end, and the sponsor withdrew funding.
I'm not expecting much from Vitaros
Dr. g c
Dr. g c
Jul 3, 2013
From my readings, can be used for all patients with ED, increase blood flow to penis. Believe onset is 15 minutes, at this time their formulation requires refridgeration however will last 7 days at room temperature. They are also planning on clinical studies Phase III of female version called "Femprox" to treat female sexual arousal disorder (there are currently no available medication to treat this disorder). They have done preliminary studies in ~500 women in China. If this all works in the real world it could be the next big ED medication. Production maybe early as 6 months--Europe or Canada, it's already approved in Canada.
Dr. Mukul Choksi
Dr. Mukul Choksi
Jun 28, 2013
Is it approved only for PD5 resistant Ed. Patients or all Ed patients ????
Dr. Mukul Choksi
Dr. Mukul Choksi
Jun 28, 2013
Approved only for PD5 resistant Ed or all Ed patients ???
Dr. Dr. EMAD AL MOSAWI
Dr. Dr. EMAD AL MOSAWI
Jun 25, 2013
This is really amazing
Dr. Julian Yong
Dr. Julian Yong
Jun 13, 2013
The only concern I would have is the topical product producing the same penile pain than the injectable one, although the report says is mild to moderate.
I guess the only way to find out would be a study comparing both methods of delivery.
Dr. montadhar nima
Dr. montadhar nima
Jun 12, 2013
Dear sir
what about the cost of vitaros and it's use , onset, and duration of action?
Dr. vk bansal
Dr. vk bansal
Jun 10, 2013
HEALTHIER LIFE STYLES MAY ALSO HELP .. GIVE HER RED ROSES ALSO ..
Dr. luis cuadrado
Dr. luis cuadrado
Jun 10, 2013
Viagra' era caput!
Recent SEEL News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:05:35 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 05/31/2024 08:30:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 08:01:36 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/20/2024 08:16:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 01:00:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 03:45:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 12:00:41 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 03/06/2024 10:32:04 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/06/2024 09:50:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:39:18 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/06/2024 10:26:45 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/02/2024 11:04:12 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 09:01:23 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/30/2024 11:05:53 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:05:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 02:47:31 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 02:47:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:16:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 02:46:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 02:45:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 02:45:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 02:45:13 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/02/2024 01:10:24 PM
DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • SONGD • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM